Telehealth policies and program integrity concerns represent two of the leading regulatory issues on hospices’ radar this year. Regulatory changes and increasing oversight were the second-most cited concerns among nearly a quarter (21%) of 112 hospice professionals who participated in this year’s Outlook Survey by Hospice News and Homecare Homebase. Challenges around staffing and improved […]
Hospices have opened doors to some of the most innovative opportunities around community and public education to help dispel barriers to greater awareness of their services. The ability to increase public awareness and community education efforts was cited as the third top concern by 16% of 112 hospice professionals who participated in this year’s Outlook […]
Hospice leaders have lost sleep over workforce pressures plaguing the industry for several years running, a trend that is not anticipated to abate anytime soon. Staffing challenges were cited as the leading concern among 35% of 112 hospice professionals who participated in this year’s Outlook Survey by Hospice News and Homecare Homebase. This represented an […]
Improved staffing conditions have turned hospice into a growth engine for Enhabit Inc. (NYSE: EHAB). Hospice currently represents about 20% of Enhabit’s patient volume, CEO Barbara Jacobsmeyer said at the HomeCare 100 conference in Florida. The segment is primed for more growth, driven to a large extent by increased clinical capacity. “[Hospice] is an area […]
Amedisys’ (Nasdaq: AMED) has halted the divestiture of some of its home health and hospice locations to Texas-based VitalCaring. Amedisys in June announced an agreement to sell some of its locations to the private equity-backed home health and hospice provider VitalCaring. The agreement included potentially more than 100 locations. The VitalCaring transaction was contingent on […]
Enhabit Inc. (NYSE: EHAB) is projecting strong hospice growth in the next year fueled in part by investments in technology and workforce development. The company is currently awaiting for the proverbial dust to settle following its victory in a recent lawsuit and the forthcoming new presidential administration. Enhabit anticipates a “nice bump” in patient census […]
Enhabit Inc. (NYSE: EHAB) expects consistent hospice growth even as it contends with payer and reimbursement headwinds for its home health business. The home health and hospice provider recently terminated its home health contract with the Medicare Advantage payer UnitedHealthcare, a subsidiary of UnitedHealth Group (NYSE: UNH), citing nine months of unsuccessful negotiations. In addition, […]
Enhabit Inc. (NYSE: EHB) has seen mixed financial results with headwinds impacting its overall revenue amid hospice tailwinds propelling these services toward sustainable growth. The home health and hospice provider formed when the company spun off from Encompass in 2022. The last year has been filled with various challenges alongside significant opportunities, said Enhabit President […]
The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come […]
Dallas-headquartered Enhabit Inc. (NYSE: EHAB) has provided a wider view into its decision to remain a standalone business. On Thursday, the company filed a preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC), part of completing its recent strategic review process. The statement detailed the company’s recent decision not to pursue a sale, […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
